Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins - sprookjes - yvandenbroek - TriplyDB

Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins

Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins

http://www.wikidata.org/entity/Q28251702

about

Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy Inflammation and cancer The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma Mitochondrial Redox Signaling and Tumor Progression Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer Oxidative stress, inflammation, and cancer: how are they linked?CXC chemokines in cancer angiogenesis and metastases Chemokines as mediators of neovascularization Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth.Cancer biomarker discovery: the entropic hallmark.Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation Chemokines: agents for the immunotherapy of cancer?Role of CXCL1 in tumorigenesis of melanoma.Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth Clinical significance of serum expression of GROβ in esophageal squamous cell carcinoma.Oncogenes in melanoma.Serum GROβ: a potential tumor-associated biomarker for colorectal cancer.Fine tuning the transcriptional regulation of the CXCL1 chemokine In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue.Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor Role of chemokines in tumor growth.Modulation of CXCL-8 expression in human melanoma cells regulates tumor growth, angiogenesis, invasion, and metastasis One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment.Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1.MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.The good and the bad of chemokines/chemokine receptors in melanoma.Multifaceted link between cancer and inflammation.Intersecting pathways in inflammation and cancer: Hepatocellular carcinoma as a paradigm.Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: role of cytokines.Epithelial barrier and oral bacterial infection.A screen for short-range paracrine interactions.NLRP3 inflammasome induced liver graft injury through activation of telomere-independent RAP1/KC axis.Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment.Stemness-related transcriptional factors and homing gene expression profiles in hepatic differentiation and cancer.Overexpression of GRO-β is associated with an unfavorable outcome in colorectal cancer.

P2860

Q22009107-902DF3D7-729B-4948-9F31-2D45D90F6113 Q24597964-59BFD7E4-3B5F-408D-9BCB-5BCDF11A11DC Q24649640-809014F7-1BF8-4C5D-A1BE-0FFD77ED63CE Q24658422-4CCD3FDA-90FF-4B96-829B-F46BD4A3EDD1 Q26749592-DCA75951-A909-49CE-9F1C-AED1C24D3EA5 Q28743229-D4932363-7D92-4AB4-8203-56BBA20522D2 Q29616835-F576B869-F731-40F6-9EF2-3185A3A623C4 Q30432791-6BD081CB-C773-44BE-9262-2AC0897C20EC Q30438032-DC86A5F0-B777-4765-A770-9761AF2B2D5D Q30439835-AB44B3F4-9570-4494-9DDB-5BD0B136888E Q30496149-A1B705E2-F3A7-4953-999F-9A2C2E77B41E Q33786919-D8524706-D269-4BB9-95B2-66100EBF764A Q34576416-51A2F2D5-7410-4FE3-A5AD-949126DA05DB Q34724089-C89BDD9B-2DF1-4638-A1DE-03158654279D Q34811043-825678F7-196C-41DF-911A-00355C98C4B3 Q35033815-2CB88CEF-6AD3-4187-BCF0-E6BC5BF560D3 Q35146560-F189D75D-C06F-44CC-B429-9FBCD9D5F908 Q35480695-C0B29B7D-83AF-47A0-9298-154E75F45127 Q35543779-401B7A24-F1C1-48A7-900F-15C896AF8612 Q35745538-7EF880E7-F86E-4286-BF64-462753658C6E Q35848571-98163A52-A058-4AE4-BC0D-8EE53A66CA3A Q36120825-6F13DB54-EAE1-4B1B-9E54-9DE2A145A8C3 Q36530744-467A2721-6AEE-4D63-89C1-AC11D707DAC0 Q36958177-12CD01A5-5692-49BF-932D-A389D1963666 Q37000605-C15B6859-D685-437F-A0A3-7FC59A8F8A25 Q37149853-4E37B9A7-D8BC-4D61-9A57-698695169026 Q37149860-CE7908E1-6C9D-4348-A8EF-473B596C143F Q37154670-A90EE26A-A468-4480-9FD3-FBC96155AC2B Q37177311-8E8B310F-44B7-4CF6-9797-1476D346625C Q37384020-234F9C41-49EC-4B7A-8C0C-3C7A8270A3CF Q37394981-3A21C29F-A657-459F-B60F-5501196A8ADB Q37943405-29A61776-B248-4299-92E7-A48EDFE797A7 Q37986022-DE44E313-4B83-448E-93EF-D52B982A0722 Q38366270-269C3A04-FEA7-416B-85EA-CD46AD875038 Q38562421-A3B55041-192D-49DC-961C-0E89DBB865ED Q38829768-15B4E722-C821-47B7-981C-117859671D3E Q38853974-8D363D5A-8AAD-4890-97D9-46CC2787738B Q38994985-A0D61085-467F-47B0-9438-50D751A5459E Q39395370-4149449D-6B25-467A-AD4B-8F491E08CFA9 Q39651723-E3145520-22C9-4281-92E4-7579A29332D4

P2860

Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins

http://www.wikidata.org/entity/Q28251702

description

1997 nî lūn-bûn

@nan

1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Enhanced tumor-forming capacit ...... tokine beta and gamma proteins

@ast

Enhanced tumor-forming capacit ...... tokine beta and gamma proteins

@en

Enhanced tumor-forming capacit ...... tokine beta and gamma proteins

@nl

type

label

Enhanced tumor-forming capacit ...... tokine beta and gamma proteins

@ast

Enhanced tumor-forming capacit ...... tokine beta and gamma proteins

@en

Enhanced tumor-forming capacit ...... tokine beta and gamma proteins

@nl

prefLabel

Enhanced tumor-forming capacit ...... tokine beta and gamma proteins

@ast

Enhanced tumor-forming capacit ...... tokine beta and gamma proteins

@en

Enhanced tumor-forming capacit ...... tokine beta and gamma proteins

@nl

P1433

Q28251702-7F4522B1-B401-441C-9D91-0B5C6D27CA13

P1476

Q28251702-FD34D945-2439-4191-B16E-827AB3AB2B74

P2093

Q28251702-3E87D0F6-87B2-4BFA-8EA8-9D2181C54244

Q28251702-448A4B8A-59A4-4758-8D1A-33D06ADBA496

Q28251702-555ED00C-0D42-46D5-91FE-11DE64219A51

Q28251702-82EFC67A-FBDC-4667-B2C3-5EB54B7EC0D2

Q28251702-A8135405-BDC8-440A-B190-0D28877D3C94

Q28251702-AE949780-CF67-45DD-8797-A12F9740DBE2

Q28251702-D8B14C31-FBAE-406C-BBD0-F7F45C4BEC23

P2860

Q28251702-29228853-D600-418C-8EC5-E0D778CD71D0

P304

Q28251702-62A7BA0C-8391-4E7E-BCB9-9CB39B6C296E

P31

Q28251702-CE071D8D-2F30-48EB-B08E-B13C168ED5BD

P3181

Q28251702-2CD82ABB-42F7-44FF-BD3A-DD497E2BAEF5

P356

Q28251702-097B7D89-2826-4269-94DC-2153CA4A291F

P407

Q28251702-198F57AD-CD8B-4007-86B7-636A2476DAF0

P433

Q28251702-24273BC5-33B4-4AE6-83F5-7C5BF600AA85

P478

Q28251702-F83AFF3C-23C4-47C3-9D06-D502DC423DF0

P577

Q28251702-9134303E-C8A6-475C-A567-3ED365B1D1D5

P698

Q28251702-F73BD80F-34F5-4933-AB94-C8535221D152

P3181

P356

(SICI)1097-0215(19970926)73:1%3C94::AID-IJC15%3E3.0.CO;2-5

P1433

International Journal of Cancer

P1476

Enhanced tumor-forming capacit ...... tokine beta and gamma proteins

@en

P2093

A Richmond

http://www.w3.org/2001/XMLSchema#string

H Haghnegahdar

http://www.w3.org/2001/XMLSchema#string

J D Owen

http://www.w3.org/2001/XMLSchema#string

L Nanney

http://www.w3.org/2001/XMLSchema#string

M Burdick

http://www.w3.org/2001/XMLSchema#string

R Shattuck-Brandt

http://www.w3.org/2001/XMLSchema#string

R Strieter

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells

P304

94-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5048322

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/(SICI)1097-0215(19970926)73:1<94::AID-IJC15>3.0.CO;2-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

1997-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9334815

http://www.w3.org/2001/XMLSchema#string